Open Orphan subsidiary signs €6m contract with European biotech company
The Dublin-listed pharmaceutical services company said it expects the contract win will generate revenue across its financial years for 2022 and 2023
The Dublin-listed pharmaceutical services company said it expects the contract win will generate revenue across its financial years for 2022 and 2023
